ArticleWiener klinische Wochenschrift2007
[The prevalence of COPD in Austria--the expected change over the next decade].
Article in Wiener klinische Wochenschrift, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.Wiener klinische Wochenschrift · 2009Pooled it
- [The effect of one year outpatient pulmonary rehabilitation on patients with COPD].Wiener klinische Wochenschrift · 2009Trial
- Adjustments to maintenance therapy and the reasoning behind them among COPD outpatients in Austria: the STEP study.ERJ open research · 2024Article
- [Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria].Wiener klinische Wochenschrift · 2020Article
- Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD).BMC pulmonary medicine · 2018Article
- Multiprofessional COPD care in Austria-challenges and approaches : Results of a qualitative study.Wiener klinische Wochenschrift · 2018Article
- Phenotypes of COPD in an Austrian population : National data from the POPE study.Wiener klinische Wochenschrift · 2018Article
- Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study.Primary care respiratory journal : journal of the General Practice Airways Group · 2013Article
- Five-year follow-up of a one-year self-management program for patients with COPD.International journal of chronic obstructive pulmonary disease · 2012Article
- The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.Wiener klinische Wochenschrift · 2009Article
- Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease.Wiener klinische Wochenschrift · 2009Article
- Elevated TNFalpha production in whole blood in patients with severe COPD: the potential link to disease severity.Wiener klinische Wochenschrift · 2009Article
- The precarious balance between 'supply' and 'demand' for health care: the increasing global demand for rehabilitation service for individuals living with chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2008Review
- [COPD today and in the year 2020].Wiener klinische Wochenschrift · 2007Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2020 Chronic obstructive pulmonary disease (COPD) will be the third leading cause of death world-wide causing considerable health costs. Epidemiological data to estimate the future development of COPD in Austria were not available so far.
methodsIn the context of the international Burden of Obstructive Lung Disease (BOLD) study, a random sample of the population of Salzburg was surveyed to determine the prevalence of COPD. The definition of COPD followed the GOLD classification. A prior physician's diagnosis of COPD, emphysema or chronic bronchitis was evaluated by questionnaire. The age- and sex-specific prevalence of COPD was extrapolated using demographic data of the Austrian population for the years 2005, 2010, 2015 and 2020. Undiagnosed COPD was considered present, whenever irreversible airways obstruction was measured (FEV1/FVC < 0.7), but a doctor's diagnosis of COPD, emphysema or chronic bronchitis has not been made.
resultsFor 2005 1.047.150 Austrians aged 40 years and older were estimated in GOLD stage I-IV. 431.080 persons over 40 years were affected by COPD in GOLD stage II-IV needing therapy. The percentage of undiagnosed COPD was 88,5%. For the years 2010, 2015 and 2020 GOLD stage I-IV COPD was projected to rise by 7,8%, 16.1% and 24%, respectively.
conclusionMeasures to prevent COPD are absolutely necessary to forestall the projected burden of this disease in Austria.
Indexed as
Identifiers
17943402What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.